Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-17

Clinical Trial Update: Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials are evaluating whether colostrum can improve gut permeability and reduce endotoxin levels in individuals with chronic alcoho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • colostrum (colostrum)

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Leaky Gut Syndrome | Phase 2, Phase 3 | Status: UNKNOWN